Global Report

May 2009
Pharmaceutical Representative;May2009, Vol. 39 Issue 5, p10
The article offers new briefs related to pharmaceutical industry worldwide in 2009. The European Commission approved the Fablyn tablets of Pfizer Inc. and Ligand Pharmaceuticals Inc. Dutch authorities was condemned by the World Health Organization (WHO) for detaining HIV patient destined for SubSahara Africa. A new guidance was issued by the Association of the British Pharmaceuticals Industry (ABPI) for the collaboration between the industry and National Health Service (NHS).


Related Articles

  • EU rejects late payment fines for public bodies. Smulian, Mark // Public Finance;5/7/2010, p6 

    The article reports on the defeat of a European Commission proposal that would have imposed fines on public bodies that pay bills late after lobbying by councils and the National Health Service in Great Britain.

  • Too close for comfort? Jack, Andrew // BMJ: British Medical Journal (International Edition);7/1/2006, Vol. 333 Issue 7557, p13 

    The article looks at drug companies in Great Britain. The article discusses patient groups, drug companies support of patient lobby groups attempting to get the National Health Service to prescribe expensive and high profile new drugs, the ban on direct drug advertising to the public, and drug...

  • The new era of collaboration. Hill, Adam // PRWeek (London);4/5/2013, p32 

    The article discusses the impact of Clinical Commissioning Groups (CCGs), a part of the new National Health Service (NHS) operations, on the pharmaceutical industry. It states that with the replacement of Primary Care Trusts (PCTs) with General Practitioner (GP) led CCGs, the NHS is looking for...

  • Pharma: Other News To Note.  // BioWorld Today;9/12/2012, Vol. 23 Issue 177, p5 

    This section offers news briefs on the pharmaceutical sector including the expansion granted by the World Health Organization to the prequalification of Pfizer Incorporated's pneumococcal conjugate vaccine and the construction completed by Takeda Pharamceuticals International GmbH for a...

  • Recent Publications, Information and Events.  // WHO Drug Information;2007, Vol. 21 Issue 4, p315 

    The article presents information on various developments concerning health and the pharmaceutical industry. It reports that the World Health Organization has set guidelines on good manufacturing practices for herbal medicines. It informs that provision of antiretroviral treatment for...

  • Drugs budget faces curb. McHale, Maria // Public Finance;02/26/99, p6 

    Reports that the government of Great Britain wants to take on the pharmaceutical industry to keep the lid on the National Health Service drugs budget. Negotiations on changes to the Prescription Pricing Regulation Scheme; Controversy over the drug Viagra and Beta Interferon; Determination by...

  • NHS loses £ millions in legal overcharging scam.  // PharmacoEconomics & Outcomes News;7/6/2013, Issue 683, p1 

    The article reports that the British National Health Service (NHS) is accusing drug companies of overcharging by more than 2,000 percent, which costs taxpayers millions annually.

  • One Man's Burden. O'Donnell, Michael // British Medical Journal (Clinical Research Edition);2/11/1984, Vol. 288 Issue 6415, p493 

    Focuses on the variety of notions associated to health in Great Britain. Issues on the administrative nomenclature of the National Health Service; Definition of health by the World Health Organization; Conditions of people in realizing the importance of health.

  • Smart Meds. T. G. // ASEE Prism;Mar2012, Vol. 21 Issue 7, p14 

    The article discusses a report by World Health Organization on the incorrect intake of prescribed medications by almost half of patients, and on approximately 690 million dollars per year being paid by Great Britain's National Health Service for improper medicine usage.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics